Nigel James Theobald

Boots Group Plc retails chemists' merchandise and auto parts; provision of opticians' and other healthcare services; development, manufacture and marketing of healthcare and consumer products

Abaco Capital Plc was a drug development company, which was engaged in re-developing approved drugs using proprietary formulation technologies. The company was founded by Marcelo Bravo and Nigel Theobald on October 7, 2009 and was headquartered in London, the United Kingdom.

N4 Pharma Ltd. operates as a drug reformulation company. The firm focuses on developing and out licensing new versions of existing and novel high value drugs with an unmet commercial or medical need. Its proprietary platform technologies include: Cocrys which is a process able to use hot melt extrusion to produce co-crystals of drugs; and Nuvac which is a nano-carrier delivery system for antigens that improves both humoral and cell mediation effects for vaccines. The company was founded by Nigel James Theobald in 2014 and is headquartered in Chellaston, the United Kingdom.

Medherant Ltd. develops transdermal drug delivery patches. It offers transdermal drug patches for skin surface and are being used increasingly for pharmaceutical products such as analgesics, alzheimer's, smoking cessation, and hormone therapy. The company was founded by David Haddleton on April 2, 2014 and is headquartered in Coventry, the United Kingdom.